Scientists have found strong genetic evidence of a link between mutations of the mevalonate kinase gene (MVK) and disseminated superficial actinic porokeratosis (DSAP). It is a major step toward ...

Porokeratosis is a rare skin disorder affecting fewer than 200,000 Americans. It typically presents as small, round patches on your skin that have a thin, raised border. Although the condition is ...

An announcement from Palvella Therapeutics ( (PVLA)) is now available. On November 5, 2025, Palvella Therapeutics announced a new product candidate, QTORIN™ pitavastatin, designed to treat ...

WAYNE, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and ...

Porokeratosis refers to a group of skin conditions that typically appear as small patches with a raised edge. In most cases, porokeratosis is not a cause for concern. However, there is a risk that ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Disseminated superficial actinic porokeratosis outcomes ...

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the development of QTORIN™ pitavastatin, a novel investigational therapy for disseminated superficial actinic porokeratosis (DSAP), a ...

While many of us will be hoping for bronzed limbs this summer, some people may emerge from repeated sunbathing sessions with a rather more unsightly side-effect - dry, scaly rings on the skin that ...

DSAP is a premalignant, progressive disease characterized by numerous expanding lesions which significantly impact quality-of-life; no FDA-approved therapies exist for the estimated more than 50,000 ...